| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Short Communications |
§
From the Cardiovascular Biology Laboratory,*
Harvard School of Public Health, Brigham and Women's
Hospital,
and Harvard Medical
School,§
Boston, Massachusetts; and Merck
Research Laboratories,
Rahway, New Jersey
To compare regulatory effects of NOS2 in acute and chronic cardiac allograft rejection, we used NOS2 knockout mice as recipients in a cardiac transplant model. To study acute and chronic rejection separately but within the same genetic strain combination, we compared allografts placed into recipients without or with immunosuppression (anti-CD4/8 for 28 days). NOS2 mRNA and protein expression were compared using 32P-RT-PCR and immunohistochemistry. In our acute rejection model, NOS2 was predominately localized to graft-infiltrating immune cells. At day 7, grafts in NOS2-deficient recipients (n = 7) showed reduced inflammatory infiltrates and myocyte damage resulting in significantly lower rejection scores (1.6 ± 0.4) compared to wild-type controls (n = 18; 2.8 ± 0.2, P = 0.002). In contrast, in our chronic rejection model, additional NOS2 expression was localized to graft-parenchymal cells. At day 55, grafts in NOS2-deficient recipients (n = 12) showed more parenchymal infiltration and parenchymal destruction (rejection score 3.8 ± 0.1) than wild-type controls (n = 15; 1.6 ± 0.2, P < 0.0001). This was associated with a significant decrease in ventricular contractility (palpation score 0.3 ± 0.1 compared to 2.3 ± 0.3 in wild-type, P < 0.0001). Hence, NOS2 promotes acute but prevents chronic rejection. These opposing effects during acute and chronic cardiac allograft rejection are dependent on the temporal and spatial expression pattern of NOS2 during both forms of rejection.
This article has been cited by other articles:
 |
|
 |
|
  G. M. Pieper, V. Nilakantan, G. Hilton, N. L. N. Halligan, C. C. Felix, B. Kampalath, A. K. Khanna, A. M. Roza, C. P. Johnson, and M. B. Adams Mechanisms of the protective action of diethyldithiocarbamate-iron complex on acute cardiac allograft rejection Am J Physiol Heart Circ Physiol, May 1, 2003; 284(5): H1542 - H1551. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. M. Pieper, N. L. N. Halligan, G. Hilton, E. A. Konorev, C. C. Felix, A. M. Roza, M. B. Adams, and O. W. Griffith Non-heme iron protein: A potential target of nitric oxide in acute cardiac allograft rejection PNAS, March 18, 2003; 100(6): 3125 - 3130. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Szabolcs, J. Sun, N. Ma, A. Albala, R. R. Sciacca, G. B. Philips, J. Parkinson, N. Edwards, and P. J. Cannon Effects of Selective Inhibitors of Nitric Oxide Synthase-2 Dimerization on Acute Cardiac Allograft Rejection Circulation, October 29, 2002; 106(18): 2392 - 2396. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Afrouzian, V. Ramassar, J. Urmson, L.-F. Zhu, and P. F. Halloran Transcription Factor IRF-1 in Kidney Transplants Mediates Resistance to Graft Necrosis during Rejection J. Am. Soc. Nephrol., May 1, 2002; 13(5): 1199 - 1209. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Qian, R. Gelzer-Bell, S.-x. Yang, W. Cao, T. Ohnishi, B. A. Wasowska, R. H. Hruban, E. R. Rodriguez, W. M. Baldwin III, and C. J. Lowenstein Inducible Nitric Oxide Synthase Inhibition of Weibel-Palade Body Release in Cardiac Transplant Rejection Circulation, November 6, 2001; 104(19): 2369 - 2375. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Kuhlencordt, J. Chen, F. Han, J. Astern, and P. L. Huang Genetic Deficiency of Inducible Nitric Oxide Synthase Reduces Atherosclerosis and Lowers Plasma Lipid Peroxides in Apolipoprotein E-Knockout Mice Circulation, June 26, 2001; 103(25): 3099 - 3104. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. F. Halloran, L. W. Miller, J. Urmson, V. Ramassar, L.-F. Zhu, N. M. Kneteman, K. Solez, and M. Afrouzian IFN-{{gamma}} Alters the Pathology of Graft Rejection: Protection from Early Necrosis J. Immunol., June 15, 2001; 166(12): 7072 - 7081. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Szabolcs, N. Ma, E. Athan, J. Zhong, M. Ming, R. R. Sciacca, J. Husemann, A. Albala, and P. J. Cannon Acute Cardiac Allograft Rejection in Nitric Oxide Synthase-2-/- and Nitric Oxide Synthase-2+/+ Mice : Effects of Cellular Chimeras on Myocardial Inflammation and Cardiomyocyte Damage and Apoptosis Circulation, May 22, 2001; 103(20): 2514 - 2520. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. F. Halloran, M. Afrouzian, V. Ramassar, J. Urmson, L.-F. Zhu, L. M. H. Helms, K. Solez, and N. M. Kneteman Interferon-{{gamma}} Acts Directly on Rejecting Renal Allografts to Prevent Graft Necrosis Am. J. Pathol., January 1, 2001; 158(1): 215 - 226. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Akizuki, T. Akaike, S. Okamoto, S. Fujii, Y. Yamaguchi, M. Ogawa, and H. Maeda Role of Nitric Oxide and Superoxide in Acute Cardiac Allograft Rejection in Rats Experimental Biology and Medicine, November 1, 2000; 225(2): 151 - 159. [Abstract] [Full Text]
|
|
|
|
|
|
X. Yang, N. Ma, M. J. Szabolcs, J. Zhong, E. Athan, R. R. Sciacca, R. E. Michler, G. D. Anderson, J. F. Wiese, K. M. Leahy, et al. Upregulation of COX-2 During Cardiac Allograft Rejection Circulation, February 1, 2000; 101(4): 430 - 438. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Drexler Nitric Oxide Synthases in the Failing Human Heart : A Doubled-Edged Sword? Circulation, June 15, 1999; 99(23): 2972 - 2975. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
